Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma.
暂无分享,去创建一个
Theodore R Holford | Peter Boyle | Nathaniel Rothman | Robert Welch | Qing Lan | Tongzhang Zheng | Stephen Chanock | Meredith Yeager | Sonja I Berndt | Yawei Zhang | Min Shen | Brian Leaderer | Bing Zhang | Kaiyong Zou | Yong Zhu | Sophia S Wang | Shelia H Zahm
[1] Theodore R Holford,et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. , 2006, The Lancet. Oncology.
[2] V. Anttila,et al. Association between chronic disseminated candidiasis in adult acute leukemia and common IL4 promoter haplotypes. , 2003, The Journal of infectious diseases.
[3] Sparholt,et al. The polymorphisms S503P and Q576R in the interleukin‐4 receptor α gene are associated with atopy and influence the signal transduction , 1999, Immunology.
[4] G. Marti,et al. Studies in NZB IL-10 knockout mice of the requirement of IL-10 for progression of B-cell lymphoma , 2004, Leukemia.
[5] S. Chanock,et al. Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia , 2005, Leukemia.
[6] R. Schwartz,et al. The role of CD28 in the activation of T lymphocytes to proliferate in response to IL4. , 1995, Research in immunology.
[7] P. Boyle,et al. Cigarette smoking and risk of non-Hodgkin lymphoma subtypes among women , 2003, British Journal of Cancer.
[8] Brian Staats,et al. SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes , 2004, Nucleic Acids Res..
[9] D. Solomon,et al. Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. , 1995, American journal of ophthalmology.
[10] M. Caligiuri,et al. A review of the association between interleukin-10 and human B-cell malignancies , 1998, Cancer Immunology, Immunotherapy.
[11] J. Blay,et al. Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. , 1993, Blood.
[12] Theodore R Holford,et al. Hair-coloring product use and risk of non-Hodgkin's lymphoma: a population-based case-control study in Connecticut. , 2004, American journal of epidemiology.
[13] S. Swain,et al. IL4 dictates T-cell differentiation. , 1993, Research in immunology.
[14] A. Fietta,et al. The frequency of interleukin-10- and interleukin-5-secreting CD4+ T cells correlates to tolerance of transplanted lung. , 2005, Transplantation proceedings.
[15] D. Harlan,et al. ASSOCIATION OF CYTOKINE POLYMORPHIC INHERITANCE AND IN VITRO CYTOKINE PRODUCTION IN ANTI-CD3/CD28-STIMULATED PERIPHERAL BLOOD LYMPHOCYTES1 , 2001, Transplantation.
[16] L. Keen. The extent and analysis of cytokine and cytokine receptor gene polymorphism. , 2002, Transplant immunology.
[17] B. Müller-Myhsok,et al. Promoter haplotypes of the interleukin-10 gene influence proliferation of peripheral blood cells in response to helminth antigen , 2004, Genes and Immunity.
[18] H. Spits,et al. Production of IL4 by human T cells and regulation of differentiation of T-cell subsets by IL4. , 1993, Research in immunology.
[19] R. Flavell,et al. Interchromosomal associations between alternatively expressed loci , 2005, Nature.
[20] R. Westendorp,et al. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[21] U. Spengler,et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF- beta production , 1991, The Journal of experimental medicine.
[22] C. Paige,et al. Interleukins 1, 4 and 6 induce the colony formation of human bone marrow B lineage cells , 1991, European journal of immunology.
[23] Stephen Chanock,et al. Candidate Genes and Single Nucleotide Polymorphisms (SNPs) in the Study of Human Disease , 2002, Disease markers.
[24] Peter Lipsky,et al. Cytokines and their role in lymphoid development, differentiation and homeostasis , 2002, Current opinion in allergy and clinical immunology.
[25] S. Heath,et al. Genomic analysis of Th1–Th2 cytokine genes in an AIDS cohort: identification of IL4 and IL10 haplotypes associated with the disease progression , 2003, Genes and Immunity.
[26] W. Ip,et al. Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus , 2004, Genes and Immunity.
[27] R. Westendorp,et al. Novel Single Nucleotide Polymorphisms in the Distal IL-10 Promoter Affect IL-10 Production and Enhance the Risk of Systemic Lupus Erythematosus1 , 2001, The Journal of Immunology.
[28] M. Clerici,et al. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases , 1996, Clinical microbiology reviews.
[29] G. Binetti,et al. Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease , 2004, Neuroscience Letters.
[30] K. Deichmann,et al. A novel polymorphism in the 5′ promoter region of the human interleukin-4 receptor α-chain gene is associated with decreased soluble interleukin-4 receptor protein levels , 2001, Immunogenetics.
[31] P. Dřevínek,et al. Association of single nucleotide polymorphisms within cytokine genes with juvenile idiopathic arthritis in the Czech population. , 2004, The Journal of rheumatology.
[32] N. Laird,et al. IL10 gene polymorphisms are associated with asthma phenotypes in children , 2004, Genetic epidemiology.
[33] D. Schaid,et al. Score tests for association between traits and haplotypes when linkage phase is ambiguous. , 2002, American journal of human genetics.
[34] L. Excoffier,et al. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. , 1995, Molecular biology and evolution.
[35] M. Harada,et al. Association between IL-4 genotype and IL-4 production in the Japanese population , 2002, Genes and Immunity.
[36] F. Davies,et al. THE USE OF BIOLOGICAL VARIABLES TO PREDICT OUTCOME IN MULTIPLE MYELOMA , 1997, British journal of haematology.
[37] Matthew W. Hahn,et al. Positive Selection on a Human-Specific Transcription Factor Binding Site Regulating IL4 Expression , 2003, Current Biology.
[38] N. Rothman,et al. Diet and nutrient intakes and risk of non-Hodgkin's lymphoma in Connecticut women. , 2004, American journal of epidemiology.
[39] D. Kunz,et al. Linkage disequilibrium between tumor necrosis factor (TNF)-alpha-308 G/A promoter and TNF-beta NcoI polymorphisms: Association with TNF-alpha response of granulocytes to endotoxin stimulation. , 2003, Critical care medicine.
[40] Ming-Tseh Lin,et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. , 2003, The New England journal of medicine.
[41] F. Martín-Saavedra,et al. Autocrine IL-4 Gene Regulation at Late Phases of TCR Activation in Differentiated Th2 Cells1 , 2002, The Journal of Immunology.
[42] R. Coffman,et al. Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.
[43] C. Wanidworanun,et al. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis. , 1993, Journal of immunology.
[44] T. Kimman,et al. Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms. , 2003, The Journal of infectious diseases.
[45] J. Antonen,et al. Th2 cytokine genotypes are associated with a milder form of primary Sjögren’s syndrome , 2005, Annals of the rheumatic diseases.
[46] G. Salles,et al. Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma. , 2004, Blood.
[47] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[48] F. Pociot,et al. Association of a functional 17beta-estradiol sensitive IL6-174G/C promoter polymorphism with early-onset type 1 diabetes in females. , 2003, Human molecular genetics.
[49] Y. Ikeda,et al. T-helper (Th)1/Th2 imbalance in patients with previously untreated B-cell diffuse large cell lymphoma , 2001, Cancer Immunology, Immunotherapy.
[50] Stephen J Chanock,et al. Mining variations in genes of innate and phagocytic immunity: current status and future prospects , 2000, Current opinion in hematology.
[51] L. Gergely,et al. Intracellular IL‐4/IFN‐gamma producing peripheral T lymphocyte subsets in B cell non‐Hodgkin's lymphoma patients , 2004, European journal of haematology.
[52] Tom R. Gaunt,et al. Polymorphisms in the interleukin‐4 and interleukin‐4 receptor α chain genes confer susceptibility to asthma and atopy in a Caucasian population , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[53] H. Mcdevitt,et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[54] D. Weisenburger,et al. An update of the epidemiology of non-Hodgkin's lymphoma. , 2003, Clinical lymphoma.
[55] K. Ardlie,et al. Alleles carried at positions −819 and −592 of the IL10 promoter affect transcription following stimulation of peripheral blood cells with Streptococcus pneumoniae , 2003, Immunogenetics.
[56] S. Weiland,et al. A complete screening of the IL4 gene: novel polymorphisms and their association with asthma and IgE in childhood. , 2003, The Journal of allergy and clinical immunology.
[57] M. Lazarus,et al. An investigation of polymorphism in the interleukin-10 gene promoter. , 1997, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[58] S. Chanock,et al. A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children. , 2002, The Journal of infectious diseases.